3D 'roadmap' aims to save more healthy lung during cancer surgery

NCT ID NCT03953144

Summary

This study is testing a new surgical technique for early-stage lung cancer. It combines 3D computer planning before surgery with a special fluorescent dye during surgery to help the surgeon see exactly which part of the lung to remove. The goal is to remove only the cancerous segment, saving more healthy lung tissue than the standard surgery. The trial will enroll 32 patients to see if this combined approach is safe and practical.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Josephs Healthcare Hamilton

    RECRUITING

    Hamilton, Ontario, L8N 4A6, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.